
Thursday, November 17, 2022 11:46:32 AM
With a market cap of less than $ 5 million
and
With a funding commitment of $ 10 million which makes no sense unless for acquisitions ( not internal / organic ) the only way to pay for these acquisitions is cash or stock
S1 registration will be done
All shall go effective hopefully for the company wishes
Major issuance and or conversions will take place with various series converting into free trading shares
Major dilution will be occurring unless addressed otherwise
Shareholders shall be reduced big time , for DMAN wants the old shareholders out of the way
Above opinion only

Liked By
Spread the love. Be the first to like this post!
Recent DMAN News
- Demand Brands Releases Annual Shareholder Letter and 2023 Forecast • InvestorsHub NewsWire • 01/10/2023 02:04:00 PM
- Demand Brands Signs Agreement to Acquire New Businesses • InvestorsHub NewsWire • 01/04/2023 03:04:29 PM
- Demand Brands engages BF Borgers CPA PC as auditor • InvestorsHub NewsWire • 06/22/2022 01:11:00 PM
- Demand Brands kicks off cultivation at Corralitos Farms • InvestorsHub NewsWire • 05/18/2022 06:00:00 PM
- Demand Brands enters $8.5 million agreement with Truleaf, Inc. to enter the live rosin market • InvestorsHub NewsWire • 05/18/2022 12:00:00 PM
- Demand Brands and Truleaf discussing the future of DB's retail footprint • InvestorsHub NewsWire • 05/13/2022 07:11:57 PM
- Demand Brands CEO Letter to Shareholders and The Year Ahead • InvestorsHub Cannabis NewsWire • 05/12/2022 03:32:00 PM
- Demand Brands Receives $390 Million Valuation from Stanton Park Advisors, LLC • InvestorsHub NewsWire • 05/12/2022 09:30:00 AM
- Demand Brands Publishes Financial Statements for Its Portfolio Companies • InvestorsHub NewsWire • 04/28/2022 05:17:29 PM
FEATURED Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders Conference • Mar 31, 2023 7:07 AM
ILUS Confirms Further Funding Arrangements and Note Settlement • ILUS • Mar 31, 2023 10:21 AM
Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K • SIGY • Mar 31, 2023 10:06 AM
ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market • ARWYF • Mar 30, 2023 10:30 AM
Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce • NTAR • Mar 30, 2023 10:00 AM
OMID Posts 2022 Annual Report and Provides Update • OMID • Mar 30, 2023 9:15 AM